Samrat Pharmachem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve the Un-audited financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Samrat Pharmachem Limited has informed BSE that its Board of Directors will meet on November 14, 2025 at 2:00 PM at its corporate office in Andheri (West), Mumbai. The main agenda is to consider and approve the Unaudited Financial Results under Ind-AS for the quarter ended September 30, 2025 (Q2 FY26). The filing is made under Regulation 29(2) of SEBI LODR Regulations, 2015. Results will be shared with the exchanges and published on the company's website after the meeting concludes. No financial figures or business updates are disclosed in this intimation.
This is a routine regulatory filing and does not, by itself, move the stock. Investors should watch for the actual results on or shortly after November 14, 2025 to assess the company's Q2 performance.